Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Prefer timeline chaos? Peptide X Quiz · Literacy certify
Pick a track — progress rings update as you complete lessons.
7 lessons
11mNo peptide is FDA-approved for building muscle in healthy adults. Here is what the human trials actually measured for growth hormone secretagogues, IGF-1 analogs, MOTS-c and the GLP-1 drugs, where each sits on the evidence ladder, and what regulators and anti-doping rules say.
10mCJC-1295 dose threads often ignore whether the vial is the albumin-binding DAC form or Mod GRF 1-29. The papers treat those as different exposure patterns. So should any educational chart.
9mIpamorelin is discussed as a selective ghrelin-receptor secretagogue with a quieter side-effect story than older GHRPs. The papers describe pharmacology. Forum charts describe habits.
9mThe GH-IGF1 axis keeps showing up in peptide medicine because it links visceral fat, recovery, and lean mass. The trick is separating the clinical signal from the wellness noise.
7mTwo 2026 peer-reviewed reviews in Sports Medicine and JAAOS now formally catalog BPC-157, TB-500, GHK-Cu, CJC-1295, and Ipamorelin stacks. Here is what the science actually shows — and where the gaps still are.
9mTwo products share the CJC-1295 name. Learn what the Drug Affinity Complex changes, what the 2006 human studies actually measured, and why the no-DAC version has far less published evidence.
9mCJC-1295 and Ipamorelin are two of the most popular GH secretagogues used together. This guide explains the differences between CJC with DAC and without DAC, how to dose them, and how to build the right protocol for your goals.
Also available at /blog for legacy links.